Exploring the Latest Updates in the Epidermolysis Bullosa Treatment Landscape

This is the second episode of a two-part educational series to raise awareness of epidermolysis bullosa (EB) and the latest FDA-approved treatment options for this disease. Our host, Dr. Michael Lavery, a Pediatric Dermatologist and Clinical Assistant Professor at the University of Florida in Gainesville, FL, is joined by Dr. Joyce Teng, MD, PhD, Professor of Dermatology and Pediatrics at Stanford University School of Medicine in Stanford, CA, as they discuss the following topics:

• Setting the stage for treating a patient with EB

• Assessing EB severity and subtype to inform treatment

• Expert review of the current FDA-approved treatments and

• Strategies to close care gaps for EB patients